You are reading 1 of 2 free-access articles allowed for 30 days
“The summary provisional data for the 2014-2015 academic year (which is still being validated) indicates a national uptake of at least HPV stage 2 of 86.1 per cent,” a HSE spokesperson told the Medical Independent (MI).
“There was some regional variation with uptake among the Community Healthcare Organisations, ranging from 77.2 per cent to 90.6 per cent.”
The HSE spokesperson emphasised that this is still “provisional data, which is still in the process of being validated”.
The target for uptake of three doses of vaccine for the routine HPV vaccination programme is 80 per cent.
To get HPV vaccine to ‘at least stage 2’ means that a girl had a stage 2 HPV vaccine recorded on the database, but she may or may not have had stage 1 or a stage 3 HPV vaccine recorded on the database.
In April, the IMO AGM heard concerns from public health doctors about a drop in HPV uptake during the recent 2015-2016 academic year.
Dr Ann Hogan, the Organisation’s Vice President and Chair of its Public Health and Community Health Doctors Committee, said recent adverse media publicity about the vaccine seems to be having an impact on uptake levels.
“I know we have had a number of parents who have withdrawn consent for the second dose of the HPV this year,” Dr Hogan told MI. The IMO passed a motion at its AGM calling for strong support for the vaccine.
There are no figures as yet for the uptake during 2015-2016 academic year.
Separately, the Department of Health defended the exclusion of the HPV and other vaccine figures from the recently-published National Healthcare Quality Reporting System (NHQRS). The report focused on MMR vaccine results.
“The inclusion of the particular indicators in the report is a function of a variety of factors, including a focus on patient outcomes, patient safety and patient care, and the availability of data in the Irish health system,” a Department spokesperson told MI.
“In relation to the selection of MMR as an indicator, it is worth noting that in addition to providing specific information on MMR vaccination rates, it can also serve as a guide to the broader uptake of earlier childhood vaccinations.
“A high rate of MMR vaccination is generally considered to be reflective of high uptake of other vaccinations.”